1 completed, 1 not yet recruiting, 1 recruiting, 1 terminated. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 1, Not yet recruiting 1, Recruiting 1, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
Follow Other: new trials by email Literature Review of Other trials Research Report on Other
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE) Cemiplimab, cemiplimab plus fianlimab, cemiplimab + REGN7075 - Colo-rectal Cancer | Phase 2 | Recruiting | NSABP Foundation Inc | 79 | 2026-04-17 | 2026-09-03 |
| Study of Precision Treatment for Rare Tumours in China Guided by PDO and NGS Albumin-Bound Paclitaxel, Epirubicin, Gemcitabine - Rare Tumour | Phase 2 | Not yet recruiting | Peking University Shenzhen Hospital | 200 | 2025-01-01 | 2024-11-18 |
| A Study to Evaluate D-1553 in Combination Therapy in Non-Small Cell Lung Cancer D-1553, Other - NSCLC | Phase 1 / Phase 2 | Terminated | InventisBio Co., Ltd | 22 | 2022-09-13 | 2024-10-15 |
| Safety and Tolerability of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis AIN457A, Other - Psoriatic Arthritis | Phase 2 | Completed | Novartis Pharmaceuticals | 28 | 2010-06-01 | 2021-06-10 |
Arthritis, Psoriatic (1) · Colonic Neoplasms (1)
InventisBio Co., Ltd (1) · NSABP Foundation Inc (1) · Novartis Pharmaceuticals (1) · Peking University Shenzhen Hospital (1)
China (1) · Germany (1) · Netherlands (1) · United Kingdom (1) · United States (1)